The Otto von Guericke University Magdeburg was founded in 1993 and is one of the youngest universities in Germany. The university in Magdeburg has about 14,000 students in nine faculties. There are 11,700 papers published in international journals from this institute.

During the past decade, Otto-von-Guericke University conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Otto-von-Guericke University" #1 sponsor was "Association of Urologic Oncology (AUO)" with 1 trials, followed by "Goethe University" with 1 trials sponsored, "Shire" with 1 trials sponsored, "Stanford University" with 1 trials sponsored and "Ultragenyx Pharmaceutical Inc" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Otto-von-Guericke University" #1 collaborator was "Aarhus University Hospital" with 1 trials as a collaborator, "CHU de Reims" with 1 trials as a collaborator, "Charles University, Czech Republic" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Epidemiological and Clinical Research Information Network" with 1 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Otto-von-Guericke University" are "Acute Myeloid Leukaemia (AML)" (1 trials), "Aneurysmal Subarachnoid Hemorrhage" (1 trials), "Apoplexy; Brain" (1 trials), "Bladder Cancer" (1 trials) and "Cerebral Stroke" (1 trials). Many other conditions were trialed in "Otto-von-Guericke University" in a lesser frequency.

Most popular intervention types in "Otto-von-Guericke University" are "Device" (3 trials), "Drug" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Best medical care" (1 trials), "Dexamethasone" (1 trials), "Intraaortic balloon pump" (1 trials) and "Panobinostat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Otto-von-Guericke University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Otto-von-Guericke University". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Otto-von-Guericke University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Otto-von-Guericke University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".